1 recruiting, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Terminated 1 |
Follow Isovorin: new trials by email Literature Review of Isovorin trials Research Report on Isovorin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia Asparaginase Erwinia chrysanthemi, Biospecimen Collection, Blinatumomab - Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia | Phase 2 | Recruiting | National Cancer Institute (NCI) | 153 | 2025-06-05 | 2026-10-27 |
| Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors Metastases Resection ( multiple steep surgery possible), 5-Fluorouracile, leucovorin L - Metastatic Colorectal Cancer | Phase 2 | Terminated | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 4 | 2014-01-01 | 2016-04-15 |
Burkitt Lymphoma (1) · Colorectal Neoplasms (1) · Leukemia, Biphenotypic, Acute (1)
Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1) · National Cancer Institute (NCI) (1)
Belgium (1) · Puerto Rico (1) · United States (1)
Erin H Breese (1) · Javier Carrasco, MD PhD (1) · Marc Van den Eynde, MD (1)
U10CA180886 (1)